America October 4, 2024
SEC Fines Cassava $40M for Misleading Alzheimer’s Drug Trial Data
Neuroscience-focused biopharmaceutical company Cassava Sciences Inc. and two former executives have agreed to pay over $40 million to resolve U.S.…
FOLLOW US
Recent Posts
Arizona
January 11, 2025
Kelly Warner Law Firm Blames USA Herald for Arizona Bar Investigation
Arizona
December 12, 2024
Arizona Bar Opens Investigation on Attorney Aaron Kelly
America
March 16, 2026
Gregory Bovino Retirement Ends Controversial Border Patrol Career
America
March 16, 2026
New Molten Planet Identified, Revealing Possible New Class of Alien Worlds
America
March 16, 2026
Bank of America Epstein Survivors’ Lawsuit Settlement Reached in High-Profile Abuse Case
America
March 16, 2026
Wiles Announces Cancer Diagnosis as White House Chief of Staff Continues Duties
America
March 16, 2026